Xwell (XWEL) Gross Margin (2010 - 2026)

Xwell (XWEL) posted Gross Margin of 35.45% for Q1 2026, down 13.15% sequentially from 40.82% in Q4 2025, and up 1667.0% YoY from 2.01% in Q1 2025.

Xwell (XWEL) Gross Margin (2010 - 2026) Analysis & Trends

Xwell has reported Gross Margin for 16 years, with the latest figure at 35.45% in Q1 2026.

Quarterly Gross Margin rose 1667.0% year-over-year to 35.45% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 29.63% (up 611.0% YoY) and the FY2025 annual result came in at 25.7%, down 62.0% from the prior year.
Gross Margin slipped to 35.45% in Q1 2026 per XWEL's latest filing, from 40.82% in the prior quarter.
Over five years, Gross Margin peaked at 40.82% in Q4 2025 and troughed at 5.42% in Q4 2022.
A 5-year average of 20.88% and a median of 18.78% in 2025 frame the typical range for Gross Margin.
The sharpest annual moves came in 2022 and 2025: Gross Margin slumped 6328 bps in 2022, then soared 2579 bps in 2025.
Over 5 years, Gross Margin stood at 5.42% in 2022, then jumped by 119 bps to 11.86% in 2023, then increased by 27 bps to 15.03% in 2024, then soared by 172 bps to 40.82% in 2025, then dropped by 13 bps to 35.45% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 35.45%, 40.82%, and 20.33% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	69.57%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	57.64%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	64.04%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	53.95%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	32.85%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	99.91%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	66.44%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	63.29%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	33.75%
10	Xwell	7.47 Mn	-9.34 Mn	2.35 Mn	35.45%

Download Data